Marta Moreira - Concepedia

Author

Marta Moreira

GlaxoSmithKline (Belgium)ORCID

Also Known As

M Moreira, M. Moreira, M., Moreira, Marta Moreira, Moreira, M., Moreira, Marta, P. J. Zimermann Teixeira

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

GlaxoSmithKline (Belgium)Finnish Institute for Health and Welfare Glaxosmithkline (Finland)FinnMedi (Finland)GlaxoSmithKline (United Kingdom)

About

Marta Moreira is an author at GlaxoSmithKline (Belgium) specializing in medicine, vaccination, and cardiovascular disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	470
2	Pharmacology	3	3	143
3	Immunology	2	2	235
4	Antibiotics	1	1	92
5	Hypertension	1	1	72

Marta Moreira

Publications

814

Citations

H-Index

Page 1

	Year	Citations
Effectiveness of the ten-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) against invasive pneumococcal disease: a cluster randomised trial Arto A. Palmu, Jukka Jokinen, Dorota Borys, The Lancet VaccinationInvasive Pneumococcal DiseaseVaccine DevelopmentImmunologyVaccine Efficacy	2012	224
Effect of pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) on outpatient antimicrobial purchases: a double-blind, cluster randomised phase 3–4 trial Arto A. Palmu, Jukka Jokinen, Heta Nieminen, The Lancet Infectious Diseases VaccinationVaccine SafetyVaccinologyPreventive MedicineAntibiotics	2013	92
Effectiveness of the 10-Valent Pneumococcal Nontypeable<i>Haemophilus influenzae</i>Protein D–Conjugated Vaccine (PHiD-CV) Against Carriage and Acute Otitis Media—A Double-Blind Randomized Clinical Trial in Finland Timo Vesikari, Aino Forstén, Ilkka Seppä, Journal of the Pediatric Infectious Diseases Society	2016	81
A two-year study on the efficacy and tolerability of policosanol in patients with type II hyperlipoproteinaemia. M Canetti, Marta Moreira, Rosa Más, PubMed Metabolic SyndromeHypertensionTwo-year StudyLipid DisorderCardiovascular Disease	1995	72
Vaccine eﬀectiveness of the pneumococcal Haemophilus inﬂuenzae protein D conjugate vaccine (PHiD-CV10) against clinically suspected invasive pneumococcal disease: a cluster-randomised trial Arto A. Palmu, Janne J. Jokinen, Heta Nieminen, STM:n Hallinnonalan avoin julkaisuarkisto (Julkari)	2014	47
Efficacy and tolerability of policosanol in elderly patients with type II hypercholesterolemia: a 12-month study Gladys Castaño, Miguel Canetti, Marta Moreira, Current Therapeutic Research 12-Month StudyLipid DisorderType Ii HypercholesterolemiaCardiovascular DiseaseElderly Patients	1995	44
Vaccine-preventable disease incidence of pneumococcal conjugate vaccine in the Finnish invasive pneumococcal disease vaccine trial Arto A. Palmu, Jukka Jokinen, Heta Nieminen, Vaccine	2018	37
Effectiveness of the Ten-valent Pneumococcal Conjugate Vaccine Against Tympanostomy Tube Placements in a Cluster-randomized Trial Arto A. Palmu, Jukka Jokinen, Heta Nieminen, The Pediatric Infectious Disease Journal	2015	32
Effects of policosanol on primary hypercholesterolemia: a 3-year open-extension follow-up Miguel Canetti, Marta Moreira, Rosa Más, Current Therapeutic Research Metabolic SyndromePrimary HypercholesterolemiaLipid DisorderOxysterolCardiovascular Disease	1997	27
Response to Primary and Booster Vaccination With 10-valent Pneumococcal Nontypeable Haemophilus influenzae Protein D Conjugate Vaccine in Korean Infants Chang Hwi Kim, Jung Soo Kim, Sung Ho, The Pediatric Infectious Disease Journal	2011	26

Page 1